Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FG9S9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,498
Award facts
- Contract value 100% obligated
- $12,497.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,497.80 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent IDC enables the company to supply a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for RINVOQ ER—a rheumatoid arthritis treatment—exemplifies the company's ongoing role in fulfilling specialized pharmaceutical needs for the federal government through the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FG9S9?
SPE2DB25FG9S9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FG9S9 worth?
The government has obligated $12,498 on SPE2DB25FG9S9.
Is contract SPE2DB25FG9S9 an order under another contract?
Yes. SPE2DB25FG9S9 is a delivery order under SPE2DB22D1103, an indefinite delivery contract.
Was contract SPE2DB25FG9S9 competed?
The extent of competition for SPE2DB25FG9S9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award